Schedule 13D ownership disclosure
BIOTIME INC
Security class unavailable · CUSIP: 09066L105
Event date: 2019-03-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 22.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-19-002304
- Form type
- SC 13D
- Filer
- Lineage Cell Therapeutics, Inc.
- CIK
- CIK 876343
- Filed
- Mar 12, 2019
- Reporting period
- Mar 08, 2019
- Description
- Schedule 13D beneficial ownership